Microbiome science to improve women’s health
9 & 10 April 2025 | Amsterdam, the Netherlands
Presented by
Artwork by Ina Schuppe Koistinen
Committee
Acting Director, Institute for Genome Sciences
Professor of Microbiology and Immunology
Ina Schuppe Koistinen
Jacques Ravel
Alliance Director Centre of Translational Microbiome Research
Kelle Moley
Vanessa K. Ridaura
Global VP of Clinical and Translational R&D, Reproductive Medicine and Maternal Health
Senior Program Officer - Microbiome Products
Johan E.T. van Hylckama Vlieg
Janneke van de Wijgert
Dirk Gevers
Chief Scientific Officer
Full Professor of Infectious and Immune-mediated Disease Epidemiology
CSO and Co-founder
Women's health is an area of medicine that has historically been under-researched and under-funded. However, there has been growing recognition of the unmet need for research and treatments in this field. Microbiome research has shown promise in addressing some of these unmet needs.
From the vaginal microbiome in reproductive health to the impact of menopause on the skin microbiome, the applications of microbiome science in women’s health are wide reaching and present an opportunity to develop novel therapeutic approaches and diagnostics.
Following the successfull inaugral event in Copenhagen in April 2024 which sold out attracting +200 attendees, the second edition of "Microbiomes in Women's Health Congress" takes place in Amsterdam on 9-10 April 2025 taking it one step further: +300 world-leading microbiome researchers, cutting-edge biotechs, and healthcare and pharmaceutical voices will unite once more to present their work on how the microbiome can be used to improve women's health.
The event will be split into chronological stages across a woman’s life spanning sessions on: exploring what is a typical vaginal microbiome, fertility, pregnancy, menopause, women-specific indications, and the development of therapeutics.